Same industry

KRYS against four biotech peers, a year at 100

100200400800Feb ’26MayAugNov ’26AMGN+29.1%GILD+31.4%MRNA×8.2BIIB+42.4%KRYS+45.7%

KRYS +45.7%. Moderna ×8.2, Biogen +42.4%, Gilead Sciences +31.4%, Amgen +29.1%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in KRYS’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

KRYS: stories, the record and filings →